<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has completed production of a A$1 million order of ArtemiCTM for leading European nutraceuticals distributor Swiss PharmaCan (TSX-V:MJN) AG (SPC) and is now ready to deliver the order. Under the terms of the agreement, the full purchase order value of about €650,000 (A$1 million) will be received by MXC by early December, positioning the company to deliver its best quarter and half yearly revenue results to date.
...read full article on Proactive Investors
